Matsumura, YasufumiPeirano, GiseleMotyl, Mary R.Adams, Mark D.Chen, LiangKreiswirth, BarryDeVinney, RebekahPitout, Johann D.D.2017-05-082017-04Matsumura, Y, Peirano, G, Motyl, MR, Adams, MD, Chen, L, Kreiswirth, B, DeVinney, R & Pitout, JDD 2017, 'Global molecular epidemiology of IMP-producing Enterobacteriaceae', Antimicrobial Agents and Chemotherapy, vol. 61, no. 4, pp. e02729-16.0066-4804 (print)1098-6596 (online)10.1128/AAC.02729-16http://hdl.handle.net/2263/60262International data on the molecular epidemiology of Enterobacteriaceae with IMP carbapenemases are lacking. We performed short read (Illumina) whole genomic sequencing on a global collection of 38 IMP-producing clinical Enterobacteriaceae (2008-14). IMP-producing Enterobacteriaceae (7 varieties within 11 class 1 integrons) were mainly present in South Pacific and Asia. Specific blaIMP containing integrons (In809 with blaIMP-4, In722 with blaIMP-6, In687 with blaIMP-14) were circulating among different bacteria in countries such as Australia, Japan and Thailand. In1312 with blaIMP-1 was present in K. pneumoniae from Japan and C. freundii from Brazil. Klebsiella pneumoniae (n=22) was the most common species; clonal complex (CC) 14 from the Philippines and Japan was the most common clone and contained In1310 with blaIMP-26 and In1321 with blaIMP-6. Enterobacter cloacae complex (n=9) consisted of E. hormaechei and E. cloacae cluster III. CC78 (from Taiwan) containing In73 with blaIMP-8, was the most common clone among E. cloacae complex. This study highlights the importance of surveillance programs using the latest molecular techniques in providing insight into the characteristics and global distribution of Enterobacteriaceae with blaIMPs.en© 2017 American Society for Microbiology. All Rights Reserved.EnterobacteriaceaeIMPMetallo-β-lactamasesMolecular epidemiologyPostprint Article